-
Article
Open AccessAssociation between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysis
Encephalopathy can occur from a non-fatal toxic drug event (overdose) which results in a partial or complete loss of oxygen to the brain, or due to long-term substance use issues. It can be categorized as a no...
-
Article
Open AccessTwin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort
We characterized the twin epidemics of new and prevalent hepatitis C virus (HCV) infections in British Columbia, Canada to inform prevention, care and treatment programs.
-
Article
Open AccessGenetic determinants of cocaine-associated agranulocytosis
Drug-induced agranulocytosis is a recognized adverse drug event associated with serious infectious complications. Levamisole is an antihelminthic and immunomodulator withdrawn from North American markets in 20...
-
Article
Open AccessA drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
In British Columbia (BC), understanding of high-risk drug use trends is largely based on survey and cohort study data from two major cities, which may not be representative of persons who use drugs in other re...
-
Article
Open AccessA cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada
Harm reduction programs are often vulnerable to political and vocal opposition despite documented evidence of their effectiveness and economic benefit. It is not well understood if opponents to harm reduction ...
-
Article
Open AccessHCV co-infection in HIV positive population in British Columbia, Canada
As HIV and hepatitis C (HCV) share some modes of transmission co-infection is not uncommon. This study used a population-based sample of HIV and HCV tested individuals to determine the prevalence of HIV/HCV co...
